Literature DB >> 2194244

Polar cap formation during cell division in Escherichia coli.

N Nanninga1, F B Wientjes, B L de Jonge, C L Woldringh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194244     DOI: 10.1016/0923-2508(90)90102-v

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


× No keyword cloud information.
  7 in total

Review 1.  Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli.

Authors:  J V Höltje
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

2.  Characterization of CrgA, a new partner of the Mycobacterium tuberculosis peptidoglycan polymerization complexes.

Authors:  P Plocinski; M Ziolkiewicz; M Kiran; S I Vadrevu; H B Nguyen; J Hugonnet; C Veckerle; M Arthur; J Dziadek; T A Cross; M Madiraju; M Rajagopalan
Journal:  J Bacteriol       Date:  2011-04-29       Impact factor: 3.490

Review 3.  Morphogenesis of Escherichia coli.

Authors:  N Nanninga
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

4.  ZipA is required for FtsZ-dependent preseptal peptidoglycan synthesis prior to invagination during cell division.

Authors:  Lakshmi-Prasad Potluri; Suresh Kannan; Kevin D Young
Journal:  J Bacteriol       Date:  2012-07-27       Impact factor: 3.490

5.  Autoradiographic analysis of diaminopimelic acid incorporation in filamentous cells of Escherichia coli: repression of peptidoglycan synthesis around the nucleoid.

Authors:  E Mulder; C L Woldringh
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

6.  FtsZ directs a second mode of peptidoglycan synthesis in Escherichia coli.

Authors:  Archana Varma; Miguel A de Pedro; Kevin D Young
Journal:  J Bacteriol       Date:  2007-05-18       Impact factor: 3.490

Review 7.  Chromosome replication, cell growth, division and shape: a personal perspective.

Authors:  Arieh Zaritsky; Conrad L Woldringh
Journal:  Front Microbiol       Date:  2015-08-03       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.